Celltrion Juggles Biosimilar Market Share As It Shifts To Direct Marketing

Korean Firm Also Settles Avastin Litigation To Allow CT-P16 Bevacizumab Launch

 
• By Chloe Kent
  
Man juggling
Market share fluctuated across Celltrion's biosimilar products. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business